The global Spatial Omics Market is estimated to be valued at US$ 267 Million in 2022 and is expected to exhibit a CAGR Of 9.4 % over the forecast period 2022-2030, as highlighted in a new report published by Coherent Market Insights.
Spatial omics refers to technologies that can analyze biological molecules such as DNA, RNA, proteins, and metabolites at high resolution spatial contexts within a tissue section, a whole slide, or an entire organ. Spatial omics helps gain insights into complex biological systems by revealing where specific biomolecules are located within intact biological specimens and how they interact with each other in space. It has applications in disease pathology, toxicology studies, developmental biology and more.
Market key trends:
The rising demand for spatial biology techniques from pharmaceutical and biotechnology companies for drug discovery and development is a key trend driving the spatial omics market growth. Spatial techniques help pharma companies gain insights into disease biology at a cellular and tissue level to facilitate development of more targeted therapies. Another major trend is the ongoing technological advancements in spatial omics techniques such as multiparameter tissue imaging and single-cell analysis which is increasing their adoption across research institutes and clinical laboratories.
The global spatial omics market is segmented by technology, application, and end-user. Based on technology, the spatial transcriptomics segment dominated the market in 2022 due to the increasing adoption of this technique for identifying gene expression patterns in tissues and cells. Spatial transcriptomics facilitates transcriptomic analysis at microscopic resolutions to determine spatial patterns of gene expression across tissues at single-cell resolution.
The global Spatial Omics Market size was valued at US$ 267 million in 2022 and is expected to reach US$ 2,670 million by 2030, expanding at a CAGR of 9.4% over the forecast period. The increasing R&D investments in spatial biology and growing adoption of spatial omics techniques across various end-use industries are fueling the market growth.
Regional analysis: North America dominated the global market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to the presence of major market players and rapid technological advancements in the region.
Key players: Key players operating in the spatial omics market are 10x Genomics, Akoya Bioscience Inc., Biognosys AG, BioSpyder Technologies, Bio-Techne, Bruker, Brooks Automation Inc., Danaher Corporation, and Diagenode. 10x Genomics dominates the market with its strong product portfolio of spatial gene expression and proteomics tools.